Overexpression of phosphorylated-ATF2 and STAT3 in cutaneous squamous cell carcinoma, Bowen's disease and basal cell carcinoma

Journal of Dermatological Science

Volumn 51, Issue 3, 2008, Pages 210-215

  Chen, Si Yuan ^a,b   Takeuchi, Satoshi ^a   Moroi, Yoichi ^a   Hayashida, Sayaka ^a   Kido, Makiko ^a   Chen, Shan Juan ^a,b   Tomoeda, Hiroto ^a   Uenotsuchi, Takeshi ^a   Tu, Ya Ting ^b   Furue, Masutaka ^a   Urabe, Kazunori ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

ATF2; Basal cell carcinoma; Bowen's disease; Squamous cell carcinoma; STAT3

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 2; STAT3 PROTEIN;

BASAL CELL CARCINOMA; BOWEN DISEASE; CARCINOGENESIS; CELL DIFFERENTIATION; GENE OVEREXPRESSION; HUMAN; KERATINOCYTE; LETTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA;

ACTIVATING TRANSCRIPTION FACTOR 2; BOWEN'S DISEASE; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; HUMANS; IMMUNOHISTOCHEMISTRY; PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; STAT3 TRANSCRIPTION FACTOR;

EID: 48049093929     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2008.04.008     Document Type: Letter

References (10)

1. Mishima K., Yamada E., Masui K., Shimokawara T., Takayama K., Sugimura M., et al. Overexpression of the ERK/MAP kinases in oral squamous cell carcinoma. Mod Pathol 11 (1998) 886-891
2. Bancroft C.C., Chen Z., Yeh J., Sunwoo J.B., Yeh N.T., Jackson S., et al. Effects of pharmacologic antagonists of epidermal growth factor receptor, PI3K and MEK signal kinases on NF-kappaB and AP-1 activation and IL-8 and VEGF expression in human head and neck squamous cell carcinoma lines. Int J Cancer 99 (2002) 538-548
3. Li C., Chi S., He N., Zhang X., Guicherit O., Wagner R., et al. IFNalpha induces Fas expression and apoptosis in hedgehog pathway activated BCC cells through inhibiting Ras-Erk signalling. Oncogene 23 (2004) 1608-1617
4. Bhoumik A., Huang T.G., Ivanov V., Gangi L., Qiao R.F., Woo S.L., et al. An ATF2-derived peptide sensitizes melanomas to apoptosis and inhibits their growth and metastasis. J Clin Invest 110 (2002) 643-650
5. Lewis J.S., Vijayanathan V., Thomas T.J., Pestell R.G., Albanese C., Gallo M.A., et al. Activation of cyclin D1 by estradiol and spermine in MCF-7 breast cancer cells: a mechanism involving the p38 MAP kinase and phosphorylation of ATF-2. Oncol Res 15 (2005) 113-128
6. Chen S.Y., Takeuchi S., Urabe K., et al. Overexpression of phosphorylated ATF2 and STAT3 in eccrine porocarcinoma and eccrine poroma. J Dermatol Sci 49 2 (2008) 170-173
7. Suiqing C., Min Z., and Lirong C. Overexpression of phosphorylated-STAT3 correlated with the invasion and metastasis of cutaneous squamous cell carcinoma. J Dermatol 32 (2005) 354-360
8. Gum R., Wang H., Lengyel E., Juarez J., and Boyd D. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene 14 12 (1997) 1481-1493
9. Ivanov V.N., Bhoumik A., and Ronai Z. Death receptors and melanoma resistance to apoptosis. Oncogene 22 (2003) 3152-3161
10. 2-kinase signaling promotes human neoplasia. Cancer Res 67 (2007) 3827-3834